Search
Pliant Therapeutics Inc
PLRXAdd to Watchlist
1.090USD
+0.010+0.93%
Close 07-24 16:00（ET）Quotes delayed by 15 min
67.49MMarket Cap
LossP/E TTM
Pliant Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-24The current valuation score of Pliant Therapeutics Inc is 8.40, ranking 97 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is -0.59, which is -42.72% below the recent high of -0.34 and -1986.10% above the recent low of -12.35.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.